Crossmark

A Qualitative Study to Explore Patient Perspectives of Prophylactic Treatment with OnabotulinumtoxinA for Chronic Migraine

Published Online: 2021-09-14

Published Print: 2021-12

Authors

Wilderman, Igor https://orcid.org/0000-0003-0499-2791
Tallarigo, Deborah

Pugacheva-Zingerman, Olga
Funding

Funding for this research was provided by:

AbbVie (Publication Grant)
License Information

Text and Data Mining valid from 2021-09-14

Version of Record valid from 2021-09-14
More Information

Article History

Received: 5 August 2021

Accepted: 1 September 2021

First Online: 14 September 2021

Document is current